Read + Share
Galili U. Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering
the coronavirus glycan-shield to present alpha-gal epitopes. Vaccine 2020 Aug 19. pii: S0264-410X(20)31073.
PMID: 32907757
|
 |
|
Galili U. Amplifying immunogenicity of prospective Covid-19 vaccines by glycoengineering
the coronavirus glycan-shield to present alpha-gal epitopes. Vaccine 2020 Aug 19. pii: S0264-410X(20)31073.
PMID: 32907757
|
|
|
|